NL-OMON50363已完成3 期
Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantation - APhIRI
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >18
- •- Recipients of a living donor kidney
排除标准
- •- Strict vegetarians or veganists. These individuals have higher potential risk
- •to an allergic reaction to the infused bovine protein.
- •- History of allergy to bovine proteins
- •- Not standard immunosuppression at time of transplantation (see protocol)
研究者
相似试验
进行中（未招募）
1 期
Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantatioIschemia reperfusion injury in living donor kidney transplantationEUCTR2017-004737-85-NLAmsterdam UMC, location VUmc40
招募中
2 期
Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function in deceased donor kidney transplantatioacute kidney injuryNL-OMON51462efrologie70
进行中（未招募）
1 期
RESCAP® rescue therapy in COVID19 diseaseCOVID 19MedDRA version: 20.0Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 100000004867EUCTR2020-001714-38-NLRed Cross Hospital Beverwijk106
尚未招募
不适用
Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19)COVID-19NL-OMON22695Rode Kruis ziekenhuis Beverwijk124
进行中（未招募）
1 期
RESCAP® rescue therapy in COVID19 diseaseCOVID 19MedDRA version: 20.0Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 100000004867EUCTR2020-001714-38-BEJessa Hospital44